What is the most characteristic metabolic abnormality in glucagonoma (a tumor of the pancreas that produces excess glucagon)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Most Characteristic Metabolic Abnormality in Glucagonoma

The most characteristic metabolic abnormality in glucagonoma is hypoaminoacidemia (option b). This distinctive feature is a hallmark of the glucagonoma syndrome and differentiates it from other pancreatic neuroendocrine tumors.

Metabolic Features of Glucagonoma

  • Glucagonoma is a rare alpha-cell tumor of the pancreas that produces excess glucagon, leading to a constellation of metabolic abnormalities 1, 2
  • The characteristic metabolic profile includes:
    • Hypoaminoacidemia - the most distinctive metabolic finding 1, 3
    • Mild diabetes mellitus/glucose intolerance - present but usually not severe 1, 2
    • Hypolipidemia/hypocholesterolemia (not hypercholesterolemia) 1, 4
    • Normochromic normocytic anemia 2, 5

Why Hypoaminoacidemia is the Most Characteristic Finding

  • Excess glucagon dramatically increases amino acid catabolism, with studies showing the percentage of leucine flux oxidized can be 50% greater than normal values 3
  • This increased amino acid breakdown leads to profound hypoaminoacidemia, which contributes to the characteristic necrolytic migratory erythema (NME) skin rash 2, 5
  • While hyperglycemia occurs in glucagonoma, it is typically mild compared to other forms of diabetes, and is not the most distinctive metabolic feature 1, 2

Distinguishing from Other Options

  • Hypoglycemia (option a): Incorrect - glucagonoma causes hyperglycemia, not hypoglycemia, as glucagon opposes insulin action and promotes hepatic glucose production 6
  • Hypocholesterolemia (option c): While present in glucagonoma syndrome, it is not as characteristic or consistent as hypoaminoacidemia 1
  • Hypercholesterolemia (option d): Incorrect - glucagonoma typically causes hypocholesterolemia, not hypercholesterolemia 1, 4

Clinical Significance

  • Early recognition of hypoaminoacidemia in patients with suspicious symptoms can lead to earlier diagnosis of glucagonoma 5, 4

  • The metabolic abnormalities of glucagonoma syndrome include:

    • Weight loss (catabolic state)
    • Mild diabetes mellitus
    • Hypoaminoacidemia
    • Hypoproteinemia
    • Hypocholesterolemia
    • Anemia 1, 2, 5
  • The definitive treatment for glucagonoma is surgical resection, which can resolve both cutaneous manifestations and metabolic abnormalities 5, 4

References

Research

Glucagonoma syndrome.

The American journal of medicine, 1987

Research

In vivo assessment of the metabolic alterations in glucagonoma syndrome.

Metabolism: clinical and experimental, 1992

Research

Glucagonoma syndrome: a review and update on treatment.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2016

Research

Glucagonoma syndrome and necrolytic migratory erythema.

International journal of dermatology, 2010

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.